Francois Brisebois
Stock Analyst at LifeSci Capital
(3.23)
# 2,487
Out of 5,023 analysts
397
Total ratings
38.5%
Success rate
2.5%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSE: DRUG Bright Minds Biosciences Inc. | Initiated: Buy | $146 | $70.59 | +106.83% | 1 | Oct 5, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $40 | $15.20 | +163.16% | 33 | Sep 30, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $31.35 | $12.01 | +161.02% | 4 | Sep 30, 2026 | |
| DRUG Bright Minds Biosciences | Initiated Coverage: Buy | $146 | $50.69 | +188.03% | 1 | Sep 28, 2026 | |
| LRMR Larimar Therapeutics | Reiterated: Buy | $25 | $2.96 | +744.59% | 10 | Sep 28, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $78 | $37.40 | +108.56% | 33 | Sep 19, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $10 | $4.55 | +119.78% | 20 | Sep 17, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $20 | $4.58 | +336.68% | 16 | Sep 12, 2026 | |
| APMD Apnimed | Reiterated: Buy | $50 | $21.51 | +132.45% | 3 | Sep 9, 2026 | |
| CMPS COMPASS Pathways | Reiterated: Buy | $24 | $11.90 | +101.68% | 18 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $9.82 | +276.78% | 6 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.38 | +110.08% | 15 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.81 | +107.90% | 32 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $719 → $754 | $295.51 | +155.15% | 31 | Aug 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $95 → $104 | $73.00 | +42.47% | 30 | Aug 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.385 | - | 27 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $39.64 | n/a | 15 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $18.50 | n/a | 27 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $80 | $28.35 | n/a | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $5.03 | n/a | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.17 | n/a | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $30 | $5.38 | n/a | 3 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $7.24 | n/a | 14 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.17 | n/a | 1 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $13.52 | n/a | 7 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $8.23 | n/a | 12 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $20 | $1.48 | n/a | 3 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $60 | $1.61 | n/a | 4 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.09 | n/a | 4 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $100 | $0.000001 | n/a | 2 | Sep 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.571 | n/a | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $72.10 | n/a | 1 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.5 → $4 | $1.12 | n/a | 2 | Sep 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $15 | $0.0001 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $72 | $6.33 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $7.48 | n/a | 2 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 | $1.54 | n/a | 1 | Jun 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.6123 | n/a | 1 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $1.15 | n/a | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $0.081 | n/a | 1 | Feb 13, 2018 |
Bright Minds Biosciences Inc.
Oct 5, 2026
Initiated: Buy
Price Target: $146
Current: $70.59
Upside: +106.83%
Dyne Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $40
Current: $15.20
Upside: +163.16%
Satellos Bioscience Inc.
Sep 30, 2026
Reiterated: Buy
Price Target: $31.35
Current: $12.01
Upside: +161.02%
Bright Minds Biosciences
Sep 28, 2026
Initiated Coverage: Buy
Price Target: $146
Current: $50.69
Upside: +188.03%
Larimar Therapeutics
Sep 28, 2026
Reiterated: Buy
Price Target: $25
Current: $2.96
Upside: +744.59%
Definium Therapeutics
Sep 19, 2026
Reiterated: Buy
Price Target: $78
Current: $37.40
Upside: +108.56%
Aquestive Therapeutics
Sep 17, 2026
Reiterated: Buy
Price Target: $10
Current: $4.55
Upside: +119.78%
Opus Genetics
Sep 12, 2026
Reiterated: Buy
Price Target: $20
Current: $4.58
Upside: +336.68%
Apnimed
Sep 9, 2026
Reiterated: Buy
Price Target: $50
Current: $21.51
Upside: +132.45%
COMPASS Pathways
Sep 9, 2026
Reiterated: Buy
Price Target: $24
Current: $11.90
Upside: +101.68%
Aug 14, 2026
Reiterated: Buy
Price Target: $37
Current: $9.82
Upside: +276.78%
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $2.38
Upside: +110.08%
Aug 12, 2026
Reiterated: Buy
Price Target: $10
Current: $4.81
Upside: +107.90%
Aug 8, 2026
Rated: Buy
Price Target: $719 → $754
Current: $295.51
Upside: +155.15%
Aug 8, 2026
Rated: Buy
Price Target: $95 → $104
Current: $73.00
Upside: +42.47%
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.385
Upside: -
Apr 8, 2025
Reiterated: Buy
Price Target: $61
Current: $39.64
Upside: n/a
Apr 4, 2025
Reiterated: Buy
Price Target: $65
Current: $18.50
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $4 → $80
Current: $28.35
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $16
Current: $5.03
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $12
Current: $1.17
Upside: n/a
Feb 28, 2025
Reiterated: Buy
Price Target: $28 → $30
Current: $5.38
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $11
Current: $7.24
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $8.17
Upside: n/a
Jul 29, 2024
Reiterated: Buy
Price Target: $36
Current: $13.52
Upside: n/a
Jul 1, 2024
Reiterated: Buy
Price Target: $6
Current: $8.23
Upside: n/a
Aug 17, 2023
Reiterated: Buy
Price Target: $90 → $20
Current: $1.48
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $8 → $60
Current: $1.61
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $5
Current: $2.09
Upside: n/a
Sep 27, 2022
Reiterated: Buy
Price Target: $80 → $100
Current: $0.000001
Upside: n/a
Jul 18, 2022
Initiated Coverage: Buy
Price Target: $18
Current: $0.571
Upside: n/a
May 11, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $72.10
Upside: n/a
Sep 10, 2019
Reiterated: Buy
Price Target: $8.5 → $4
Current: $1.12
Upside: n/a
Sep 4, 2019
Reiterated: Buy
Price Target: $23 → $15
Current: $0.0001
Upside: n/a
Sep 4, 2019
Reiterated: Buy
Price Target: $68 → $72
Current: $6.33
Upside: n/a
Jul 29, 2019
Reiterated: Hold
Price Target: $1.5 → $1
Current: $7.48
Upside: n/a
Jun 27, 2019
Upgraded: Buy
Price Target: $50
Current: $1.54
Upside: n/a
Feb 20, 2019
Reiterated: Buy
Price Target: $11
Current: $0.6123
Upside: n/a
May 24, 2018
Reiterated: Buy
Price Target: $26
Current: $1.15
Upside: n/a
Feb 13, 2018
Reiterated: Buy
Price Target: $210
Current: $0.081
Upside: n/a